Riskpilot← Back to searchSign inGet full accessTANNSPES AS
ASActiveOrg 921660529Holmenveien 5G, 0374 OsloDental practice care activities · NACE 8623Est. 20185 employees
Revenue 2025
NOK 5,9M
-23% vs 2024
EBITDA margin
-25.4%
-168% vs 2024
Equity ratio
26.3%
Financial strength
Net profit 2025
NOK -1,3M
-155% vs 2024
| Revenue | NOK 5,9M | -23% |
| EBITDA | NOK -1,5M | -168% |
| Net profit | NOK -1,3M | -155% |
| Total assets | NOK 1,9M | -32% |
| Equity | NOK 495K | -45% |
| Employees | 5 | — |
Legal name
TANNSPES AS
Org number
921660529
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
3. november 2018
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av tannhelsetjenester og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller annen måte gjøre seg interessert i andre foretak.
Address
Holmenveien 5G, 0374 Oslo
Phone
+4722205050
Email
post@tannspes.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 732 | 6 973 | 8 246 | 7 740 | 5 931 |
| Staff expenses | −1 115 | −1 640 | −1 495 | −1 870 | −1 622 |
| EBITDA | 330 | −1 022 | −933 | −563 | −1 507 |
| Depreciation & amort. | −9 | −7 | −23 | −55 | −25 |
| EBIT | 321 | −1 030 | −956 | −618 | −1 532 |
| Net financials | −30 | −46 | 50 | −22 | −13 |
| Profit before tax | 291 | −1 075 | −906 | −640 | −1 546 |
| Tax | −101 | −0 | −0 | −132 | −252 |
| Net profit | 391 | −1 075 | −906 | −508 | −1 294 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 777 | 3 930 | 2 731 | 2 771 | 1 887 |
| Equity | −1 673 | 603 | 937 | 897 | 495 |
| Long-term debt | 854 | 604 | 716 | 504 | 0 |
| Short-term debt | 1 596 | 2 723 | 1 078 | 1 370 | 1 392 |
| Total debt | 2 450 | 3 327 | 1 794 | 1 874 | 1 392 |
EBITDA margin
-25.4%
This company
15.8%
Market median
-261% vs market
20212025
Equity ratio
26.3%
This company
38.2%
Market median
-31% vs market
20212025
Return on equity
-261.2%
This company
18.4%
Market median
-1520% vs market
20212025
Net profit margin
-21.8%
This company
8.1%
Market median
-369% vs market
20212025
Asset turnover
3.14×
This company
1.12×
Market median
+180% vs market
20212025
Debt / equity
2.81×
This company
0.62×
Market median
-353% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KI Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
TM Chief Executive Officer | Chief Executive Officer | 2019 – 2023 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oslo Implantatsenter As
TANNSPES AS Board members of TANNSPES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turid Mørch | Chief Executive Officer | 0 companies |
| Karl Iver Hanvold | Chief Executive Officer | 0 companies |